Showing 1 - 3 results of 3 for search 'Arlene O. Siefker-Radtke', query time: 0.03s Refine Results
  1. 1
    Multimodal kidney‐preserving approach in localised and locally advanced high‐risk upper tract urothelial carcinoma

    Multimodal kidney‐preserving approach in localised and locally advanced high‐risk upper tract urothelial carcinoma by Omar Alhalabi, Matthew T. Campbell, Lianchun Xiao, Ana C. Adriazola, Nathaniel R. Wilson, Arlene O. Siefker‐Radtke, Paul G. Corn, Amado Zurita, Eric Jonasch, Jianjun Gao, Mehrad Adibi, Ashish M. Kamat, Neema Navai, Louis L. Pisters, Colin Dinney, Surena F. Matin, Amishi Y. Shah

    Published 2022-01-01
    Get full text
    Article
  2. 2
    Bempegaldesleukin plus nivolumab in first-line renal cell carcinoma: results from the PIVOT-02 study

    Bempegaldesleukin plus nivolumab in first-line renal cell carcinoma: results from the PIVOT-02 study by Mario Sznol, Adi Diab, Jonathan Zalevsky, Ute Hoch, Mehmet A Bilen, Giovanni Grignani, Nizar M Tannir, Erika Puente, Arjun V Balar, Daniel C Cho, Arlene O Siefker-Radtke, Lily Tang, David Chien, Arkopal Choudhury, Danni Yu, Sue L Currie, Mary A Tagliaferri, Michael E Hurwitz

    Published 2022-04-01
    Get full text
    Article
  3. 3
    Management of Fibroblast Growth Factor Inhibitor Treatment–emergent Adverse Events of Interest in Patients with Locally Advanced or Metastatic Urothelial Carcinoma

    Management of Fibroblast Growth Factor Inhibitor Treatment–emergent Adverse Events of Interest in Patients with Locally Advanced or Metastatic Urothelial Carcinoma by Arlene O. Siefker-Radtke, Andrea Necchi, Se Hoon Park, Jesús García-Donas, Robert A. Huddart, Earle F. Burgess, Mark T. Fleming, Arash Rezazadeh Kalebasty, Begoña Mellado, Sergei Varlamov, Monika Joshi, Ignacio Duran, Scott T. Tagawa, Yousef Zakharia, Keqin Qi, Sydney Akapame, Spyros Triantos, Anne O'Hagan, Yohann Loriot

    Published 2023-04-01
    Get full text
    Article

Search Tools: